Primary Site >> Biliary tract Cancer

Gene >> SDC1

  • 2003
  • 2008
  • 2009
  • 2012
  • 2015
  • 2017
Ref: Reduced expression of syndecan-1 correlates with histologic dedifferentiation, lymph node metastasis, and poor prognosis in intrahepatic cholangiocarcinoma.
PMID: 14562280
Ref: Syndecan-1 expression in gallbladder cancer and its prognostic significance.
PMID: 18544939
Ref: Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
PMID: 19259612
Ref: Expression of syndecan-1 and E-cadherin is inversely correlated with poor patient's prognosis and recurrent status of extrahepatic bile duct carcinoma.
PMID: 19420730
Ref: Thyroid-like cholangiocarcinoma of the liver: an unusual morphologic variant with follicular, trabecular and insular patterns.
PMID: 23109464
Ref: Molecular biology of gallbladder cancer: potential clinical implications.
PMID: 23112962
Ref: [Relapsed/refractory multiple myeloma with CD138 shedding and formation of extramedullary disease in the common bile duct region presenting as obstructive jaundice].
PMID: 26345572
Ref: Heparanase overexpression down-regulates syndecan-1 expression in a gallbladder carcinoma cell line.
PMID: 28351285